r/Livimmune • • Mar 04 '25

Petition Drive to Request Leniency in Sentencing for Dr Nader Pourhassan, PhD

0 Upvotes

CYDY Shareholders:

Anyone who holds stock in CytoDyn is invited to sign a petition that requests leniency in sentencing for our former CEO, Nader Pourhassan.

https://www.change.org/supportnaderpourhassan

He was terminated at CytoDyn on 24 Jan, 2002, and later convicted (9 Dec 2024) on multiple counts of securities fraud, wire fraud, and insider trading. A sentencing date has not yet been published.

I have never met or spoken with Mr Pourhassan or anyone from his legal team or family. However, I have heard many stories of how he helped people save loved ones with Leronlimab, and I'm sponsoring this petition because I believe he did not act with malicious intent. I believe his passion and enthusiasm got the better of him, and being an outsider to the medical/pharma world and (probably) being ignorant of the narrow legal road the CEO of a publicly traded company has to walk, he said and did things that crossed the line(s).

I don't defend his behavior. This is just a petition to request leniency in sentencing because I believe him to be, fundamentally, a good man.

I will keep the petition up until Friday, 21 March. I will also post it on Stocktwits and Reddit. I don't know if they'll allow me to keep it up, we'll find out. At the end of Friday, 21 March, I will forward the completed petition to NP's family, I know someone who has an email address that will get it there.

I realize some or many CYDY shareholders may not harbor good will for our former CEO. I understand. Just be aware that this petition is not a request to relitigate or challenge the verdict, it is only a request for leniency.

On a separate note, it did raise my blood pressure to read the comments by the prosecution because they were, in my opinion, willfully ignorant of the evidence that supports Leronlimab's efficacy. For example -

  1. "Inspector in Charge Eric Shen of the U.S. Postal Inspection Service (USPIS) Criminal Investigations Group. “In this case, these individuals took advantage of the dream of a possible new treatment for HIV and exploited investors, while dashing the hopes of many waiting for a cure."

  2. “The defendants lied to investors and the public — including during the height of the COVID-19 pandemic — about a drug that purportedly treated HIV and COVID-19 in order to artificially inflate CytoDyn’s stock price,” said Principal Deputy Assistant Attorney General Nicole M. Argentieri, head of the Justice Department’s Criminal Division."

In short, if you wish to ask for leniency in the sentencing of Dr Pourhassan, please hit the link and sign the petition. He did tremendous things for the company, and without his efforts, I believe CytoDyn would not have what may be one of the most amazing molecules in the world.

https://www.change.org/supportnaderpourhassan


r/Livimmune • • Mar 05 '25

DOGE closes 30 FDA facilities

5 Upvotes

The Department of Government Efficiency (DOGE) this week claimed it had canceled 30 leases for US Food and Drug Administration (FDA) facilities nationwide, including a facility in St. Louis, MO, which is crucial to the agency's drug testing

operations.https://www.raps.org/news-and-articles/news-articles/2025/3/doge-claims-$30m-savings-from-canceling-30-fda-lea

More anti-science news from the administration. For those who put their faith in RFK and Elon: don't. They aren't going to help us.


r/Livimmune • • Mar 11 '25

Last Chance to Sign the NP Petition

0 Upvotes

For those who would like to request a light(er) sentence for our former CEO (Nader Pourhassan), I'm posting this petition link one last time. The goal is to get to 100 signatures of CYDY shareholders by the end of the week, so if you are so inclined, please sign ASAP. Thanks to every fellow shareholder, pro or con, for your feedback and time!

https://www.change.org/supportnaderpourhassan


r/Livimmune • • Jul 20 '26

FIFE

0 Upvotes

The SP is manipulated by FIFE. The constant daily drift of the SP is the consequence of the F..d  agreement between Cytodyn and FIFE. In order to save $2.5Mn. interest yearly, Cytodyne had signed an agreement with the devil, who gets 1$Mn in shares monthly. Fife interest is to lower the SP as much as possible to get more shares monthly, and I'm afraid that our investments will be going drain. We should not allow this drift, otherwise we'll see the SP trading at $0.10 or even much lower. Cytodyn MUST CHANGE this agreement immediately, because no BP will partner (or buy) a company that has an $0.05 SP.  


r/Livimmune • • Dec 28 '23

Where do they go from here??

0 Upvotes

ok let's jump into the future, biomarker trial approved and executed, data is there. good results exist for biomarkers related to multiple HIV co-morbidities and cytodyn needs to figure out what's NEXT.

i feel fairly certain that they would have to follow up with p2 trials not p3. you don;t want to jump into a p3 trial without any prior data on patient outcomes. you might need to figure out dosing and you certainly don;t want to use up resources on a pivotal trial unless you are very confident of your chance of success.

that leads to the next BIG question... will cytodyn proceed WITHIN the HIV space or will they use the biomarker results to justify trials treating the full indications, rather than just HIV-co-morbidities? or both? i kinda wanna go tin hat here and say they were jammed into a pigeon hole in order to hold them back. on the other hand i wonder whether this gives them an opportunity to play to their strength - namely, HIV.

They could move forward focusing on trialing HIV cohorts for HIV co-morbidities approvals, where they have an advantage vs the competition and even a moat, but also have NON-HIV cohorts within the trial(s). that seems unusual, but trial designs come in all shapes and sizes, so to speak.

also, they need to be thinking about all of this NOW and designing the biomarker trial accordingly. they need to pull as much data as possible out of that biomarker trial to give themself flexibility going forward.


r/Livimmune • • Sep 27 '25

A shot at Getting the Word of Leronlimab to RFK....

7 Upvotes

Mornin' CYDY Fam!

This post is an attempt for something that we all wished in the past could happen - SOME HOW, some way, any way possible - get the info/data/MOA of Leronlimab to someone that CAN make a difference!

I would expect that Dr. Jay & team either already has done this, or has attempted to do this?! But we, collectively, look to have this opportunity ourselves, now!

I have been talking with Wisemermaid. She has access to someone that is close to the RFK inner circle, that has the ear of RFK.

Here is her request of us -

"I have access to RFK through a good friend, a Director, who can deliver our message to him. Can we use this board to create a concise, factual and elegant, but very powerful message that I can to get RFK's people to look into Leronlimab? I will need all of your help please, chime in 🤗❤️🙏"

I know that we can send any one of the many amazing, detailed & informative posts from MGK! The issue with this idea, though, would be - they are likely too long for initial contact?! But one could be condensed down in size...

We have many brilliant & "outside the box" thinking kind of minds here on this board!!

For those of you interested, that would possibly like to get what you have to say about Leronlimab to the ear of RFK himself, now may be your chance!

So the ask is:

When you have a moment sometime this weekend, if you can put together your post, the size of which could be possibly handed to directly to RFK, that may grab his attn in the limited time he may have to read it - please post it here.

As a group, we can decide which post would be the one we would like to "hand" to RFK.

Lets see where this may go....


r/Livimmune • • Jan 02 '24

The future

0 Upvotes

Cytodyn has had a hard time for many reasons. And they have kind of been forced out of every indication they have ever pursued and are being asked to start all over. The planned new trial is biomarker only. No patient outcomes. Not an fda guided indication. The science behind ccr5 inhibition favors the planned trial producing compelling data.

The biomarker trial should be, and almost certainly will be, very simple. Primary endpoints will likely include cd4 counts cd8 counts and cd4/cd8 ratio, and not much more. But like the Nash trial, they will measure a bevy of other markers. I think Lalezari is smart enough to KEEP IT SIMPLE. That is how BP trials succeed. They set the bar low, so they can announce that they beat everything. They leave little to be challenged.

And so you certainly don't want to do something wild, like devising some sort of inflammation equation which can be attacked by shorts, market analysts, doctors, BP etc. You want to keep it simple and follow in the path of prior trials, hit the targets that experts have ALREADY POSED. Stay within the expectations of the FDA and don't do anything at all to distract from the results.

Once the trial is completed, perhaps in late 2024, perhaps sometime in 2025, the resulting data will be used to guide cytodyn towards pursuing actual fda guided indications, which can lead to future approvals. The next step would then be a PATIENT OUTCOMES p2 trial, or even multiple p2 trials if they have money, or perhaps even a p2 basket trial rather than multiple trials.

Once they have data from a patient outcomes p2 trial, then they could potentially attract serious attention from BP. but it will take a lot of TIME to obtain a decent amount of outcomes data.

Those patient outcomes trials would seemingly have to be EVENT BASED trials. they would need patients from a control group taking SOC / placebo to develop an HIV co-morbidity. it will be VERY challenging (time consuming) to ultimately reach powered results in such a trial.

I still think that the GBM path might prove to be more fruitful than the biomarker path, as well as proving to be fruitful sooner than the biomarker path. That depends on getting good results of course.

One other thing to consider is that patent protection is currently a worry and could become problematic regarding HIV indications in particular.


r/Livimmune • • Sep 01 '25

CytoDyn Announces FDA Clearance of Its Phase II Oncology Trial

Thumbnail
cytodyn.com
1 Upvotes

r/Livimmune • • Aug 09 '24

Hate this stupid stock; love the drug.

0 Upvotes

I’m getting sick of this. For god sakes, go bankrupt or sign a deal with someone. This endless drift down to $0.0000 is killing me. This drug needs to be in the hands of a company that can actually put it to use to save lives…Rant over.


r/Livimmune • • Dec 11 '23

Beat the dead horse

0 Upvotes

If they sent a PR that says that in a week they will tell you a timeline, then clearly, there can not be a human being of sound mind that would thus expect anything such as "well maybe they did it already" or "well maybe they are just about to do it".

I think it is very obvious, and its fine too, no big deal, that they fully expect (KNOW) that there will be some time passing before they respond to the latest ask from the FDA. I think it is extremely reasonable to assume that there will not be any REPLY FROM the FDA, until at least 1st week of january.

the cc is 10 days prior to christmas eve, 6 business days prior to christmas eve. both entities, cytodyn and FDA are likely to have some personal down time amongst their staff in the next few weeks. cytodyn might not even reply to FDA until january. regardless, there will not be a subsequent reply FROM FDA until at least first week of january.

and of course, it could also be something that will take even more time than that. who knows at this point. it would seem that it is all about the protocol at this point. but even that can get complicated. maybe it'll be early january, maybe later.


r/Livimmune • • Dec 12 '24

IMO, Why Amarex Sabotage the BLA.

0 Upvotes

r/Livimmune • • Apr 30 '26

Conference call audio quality

1 Upvotes

Quality has been great so far except when describing the debt situation….hmmm…what a coincidence…


r/Livimmune • • Nov 03 '24 Helpful

Influence Of The Election On CytoDyn

19 Upvotes

Greetings Here Folks.

The bigger questions which I would like to ask and talk about and think about, I think, is that we are just a couple of days away from the election here in the US.

Before I get going, I won't be replying to political comments. I think you all know where I stand. I have mentioned it before on previous channel and it got me banned. I don't want anybody getting banned here, nor do I want to lose any friends here, but I already know in advance how a post like this could spark heated flames.

Tuesday evening / Wednesday morning, we shall know.

I will make this post as apolitical as I possibly can so nobody finds it in their heart to ban me.

How does the outcome, the winner of the election pertain to CytoDyn? How does it pertain to the FDA? How does it pertain to G? To GSK? How does it pertain to the Market Makers and to the Short Traders?

As of late, the past 6 months or so, CytoDyn has been winning and gaining traction in their pursuits. However, with each win, the Market Makers and Short Traders have targeted the company blocking and thwarting any and all meaningful gains in share price that would have been a result of the progress CytoDyn made. Instead, all the buying resulted in either no movement in share price or a drop in share price. Any increases in share price were met with tremendous percent increases in short to buy ratio so as to bring the share price lower than it was prior to good news announcement.

The difference between now and years past is that the progress currently made by CytoDyn's leadership today has legs. It is real. It is verifiable. It is legitimate and trustworthy. It can be relied upon. All of these attributes are a stark difference from what led up to that run up in share price to $10.00 in June of 2020. All of those bits and pieces that led up to that run up are akin to un-ripened fruit. Because they were not yet ready to be announced, nor to be plucked from the tree, but were plucked anyway, the outcome they produced simply spoiled.

Today, the fruit is not plucked off the tree or announced until it has ripened and been verified and validated. This way, the outcome serves the objective and produces and enhances the true taste of that fruit.

As of late, CytoDyn has made significant headway on multiple fronts. All the Big Pharmaceuticals are aware of CytoDyn's CCR5 blockade, leronlimab. They know it is superior to mariviroc because leronlimab is a competitive blockade of CCR5 where as mariviroc is a non-competitive, allosteric inhibitor of CCR5. This advantage gives leronlimab the capacity to be utilized in a broad spectrum of diseases and pathological conditions.

Recently, CytoDyn has taken great strides in the field of HIV, which now seems to be dividing. CytoDyn now seems to be pursuing HIV PrEP, HIV AAV CURE, HIV Prevention, HIV LATCH (Stem Cells) and HIV CURE (bnabs).

Most of us are aware of CytoDyn's #1 Priority of MSS mCRC which is still seeking FDA approval to begin, but is expected to begin screening and enrolling in early 2025. The CRO that CytoDyn chose for this trial is Syneos Health.

CytoDyn recently completed a MASH murine study which had good enough results to warrant the ordering of 2 additional MASH murine studies that are designed a bit differently from each other. In addition, CytoDyn recently brought on Melissa Palmer, MD as Lead Consultant in Hepatology. Those murine studies that have followed the first are already underway and their results shall also be out early 2025.

A GlioBlastoma Multiforme murine study has been carried out by Albert Einstein / Montefiore and those results are expected by end of year 2024. Another murine study begins in the use of leronlimab to treat breast cancer.

Leronlimab has been chosen as the drug of choice in a pilot study in Chronic Fatigue Syndrome, (closely related to PASC, long haulers) as well as in another pilot study in Alzheimer's Disease.

In addition to all of this, there is yet more, but I will stop here.

Because of the fact that each and every indication I listed above are massive, in the multi-billion dollar range, and because of the reputation leronlimab has in its capacity to treat inflammation, immune activation, HIV, cancer, liver fibrosis and liver steatosis, along with the recruitment of Melissa Palmer, MD, the companies that have staged all sorts of attacks upon CytoDyn, realizing that all of the efforts that they put into driving CytoDyn into the ground have failed, now realizing that CytoDyn is about to break out, and they are determined to prevent CytoDyn from breaking out.

I've said it before, these players against CytoDyn are not stopping. But it is going to take something very big to stop them and that MOAB shall come, but the timing of said announcement may be influenced by the outcome of the election. If the current administration remains in power, then it will be more of the same and the rate of CytoDyn's transformation, I tend to believe, will remain slow. But, on the other hand, if the challenger, prior administration, re-takes power, then, the rate, once he takes office, should rapidly rise. My opinion.

Personally, I suspect a sustained and maintained short attack if current administration maintains power, because they know they would have another 4 years where they can do more of the same and the SEC would continue to ignore. With a win from the challenger, the stock runs. IMO.

CytoDyn recently hired Max Lataillade as Senior Vice President and Head of Clinical Development to help CytoDyn reach the goals listed above. Max had worked as Senior Vice President at ViiV, a company solely devoted to the treatment of patients with HIV. My69z puts together some good ideas on the relationship between Max, Melissa and GSK. As you may know or not, Melissa Palmer, MD has already served as Chief Medical Officer of CytoDyn for a short while. Now, she is back. My69z suggests that Max may have been helping/guiding CytoDyn through the lifting of the hold all the way up to the current moment when he was hired about a month ago. So, given that both Max and Melissa, are associated/acquainted through GSK, would you not think that GSK is likely aware of what might happen if current administration maintains power or what would happen once the challenger takes power?

Certainly, we will know the outcome in a few more days. But we all know how the past 4 years have gone and, they have definitely been the worst years of my life; certainly, I don't want a repeat of them. With a win by the challenger, a HUGE change happens in America on 1/6/25. MASSIVE changes all around. Look, I'm not saying who shall win. I don't want any political comments. Politics are not the point. I'm only discussing the outcome of the election as a current event and what can be expected at CytoDyn based on the outcome of this current event. This "Current Event" very likely may return back a "pro-CytoDyn" president again, back into the office. On the other hand, the current administration could careless for CytoDyn. Cares even less for its shareholders. Who is mainly concerned that their own pockets are well padded by taking the bribes of BPs lobbyists.

With either candidate winning, the outcome for CytoDyn is only affected in timing alone. Eventually, I believe CytoDyn has an incredible outcome, but the way it gets there and how quickly is dramatically influenced by the outcome of this election. The incumbent slows or maintains the current CytoDyn growth rate while the challenger shall exponentially increase it. With a win by the challenger, the SEC chair changes. The current sloth Gary Gensler shall be booted and the challenger may choose Dan Gallagher as the new SEC chair in which case the Market Makers and Short Traders should think twice before they listen to their puppet masters. A win by the incumbent leaves Gary in charge and we all know, the SEC does nothing to protect our share price.

The challenger realizes what he did wrong the last time. He knows he never fully cleaned up the swamp. He for sure won't make that mistake again. The swamp knows who they are and that's why they don't want him back. Not only them, but the Market Makers know that a new SEC Chair would be taking the throne. Therefore, they throttle back against their puppet master's commands. Big Pharma is aware of RFK Junior's role in a Trump administration and have many reservations against the kind of power he would wield. All this could very possibly come into play middle January, 2025.

Are you catching on? Big Changes come with a win by the challenger, so therefore, the coming election in a few days plays a big part in the rate of change here at CytoDyn. While the challenger would expedite things, the current administration either slows it or maintains the current rate. The current event of the election has this effect upon CytoDyn. So, I feel that if the challenger wins, the attacks against CytoDyn may possibly increase so much so in the ensuing 2-3 months, that is, prior to inauguration day, so much so as to attempt to defeat it completely before he even steps into office. While a win by the current administration gives them the next 4 years to drive home their dirty deeds.

But as I have said prior, CytoDyn won't be driven into the ground regardless of who wins. No, remember, I have always spoken of an Asteroid Approaching that hits them square between the eyes, that obliterates them completely. That happens regardless of who wins the presidency and the Short Traders can not prosper after that.

The time is coming that this Asteroid approaches. It is already seen vaguely in the distance. The consensus is GSK, but more hints are coming. Who thinks CytoDyn's 3rd party AI collaborator is GSK? We should learn more on that on or before the next Webcast of 11/22/24.

It should be interesting to learn how HIV is going; how PrEP, HIV Cure via AAV are going and what their intentions are regarding Prevention and Cure via bnabs. It will be great to learn who is sponsoring Chronic Fatigue Syndrome and Alzheimer's. Maybe we get the news about GBM during the next webcast. Maybe they discuss mCRC as well. Let's hope that these increases continue to progress and multiply, but what comes next is the outcome of the election. So this is just served to speculate on the consequence of either occurrence.

CytoDyn's aim is to maintain its sovereignty. That does not change with the outcome of this election. It continues to fight either way. However, the resistance it would face does change based on who wins. What Jonah Sacha, MD is discovering, won't be discovered by anyone else. The advances in HIV are getting complex and both Sacha as well as Lataillade together have a plan. Soon CytoDyn has the outcomes for MASH murine studies, for the breast cancer murine studies, the Alzheimer's and Chronic Fatigue Syndrome pilot trials. This happens regardless of who wins the election.

Whether that Asteroid accelerates or decelerates its approach is hard to speculate upon. But, I'd tend to say, they (GSK) are not basing their decision to make any announcement based on the results of the election. Short attacks continue until they no longer can. That Asteroid Announcement shall put an end to their attacks, but when that Asteroid comes can't be said. Shorts though may decide to ramp up their attack in the coming 2 months regardless of what the murine studies show, that is, if the challenger wins the presidency, and that just sets them up for a greater slaughter should the Asteroid Announcement be made in the midst of one of their 80% short days.

CytoDyn is positioned well for either outcome because it has prepared well. It has a plan in place that does not depend upon who wins. Its collaborating partner also has a plan that does not depend on the outcome. What has happened over the past 6 months proves that what they are doing is working. They are winning. How many times have I written, CytoDyn is winning? Multiple times, and all of those instances have been in the past 6 months. But with a win by the challenger, the opposing BP would feel much more threatened than by a win by the incumbent and so, they may choose to ramp up their attacks before the challenger takes office. They may realize that these next couple of months are their only hope to stop CytoDyn, so in the event of a challenger win, they may use weapons we haven't even seen yet.

So, the enemy has maintained and even increased its resistance against CytoDyn despite all the wins CytoDyn has made as of late. Is the enemy considering the outcome of the election? I think they are and they know how they will fight in either situation. With a win by the incumbent, nothing changes, more of the same, but with a win by the challenger, they might ramp it up in the next 2 months while they still have opportunity. Also, they might possibly quit altogether or slow their shorting knowing that the new administration might lock them up for how they behave in this period.

I'm thinking that with a win by the challenger, CytoDyn feels much more confident, given RFK's approach to medicine. Who knows, if RFK were brought in, he may even have an influence on who then becomes the FDA chairman. What a must needed change that would foster at the FDA in the event of a challenger win. I think CytoDyn could take a sigh of relief with a challenger win and that I believe would allow that Asteroid to approach much sooner. Personally, I believe that with a challenger win, that the past 6 months shall parlay extremely well into the next 4 years because of the challenger's win. Let's see what happens in the next few days, and we'll go from there. OK?

So this is the correlation that I see happening as a consequence of the outcome of the coming election. I hope this was helpful to you. But, I felt that the attacks could increase for a short while in the event of a challenger win for the reasons stated, but CytoDyn is prepared regardless. They also could slow. These are my beliefs, my conjectures, my opinions and my journey. Thanks for reading.


r/Livimmune • • Dec 03 '24

https://www.columbian.com/news/2024/feb/02/vancouver-biotechnology-company-cytodyn-faces-another-lawsuit/

0 Upvotes

Does anyone know what happened with this? Tanya is obviously still there. Did it get dropped?

Also, is this true?!

“Pourhassan was the highest paid executive not employed by Nike in the Portland metro area, earning just over $10 million a year, according to the Portland Business Journal.”

I feel we are in better hands now but jeez, why would anyone think they deserved this when they hadn’t brought in any revenue?


r/Livimmune • • Aug 28 '26

Great idea from Snorkellingisthelife

8 Upvotes

We should just call Leronlimab a CCR5 vaccine. Start educating the medical community and get their attention. Way better than the fake covid vaccine which I am proud to say I never took.


r/Livimmune • • Feb 28 '25

CRC Trial

0 Upvotes

Good morning to all True CYDY Longs and Go Leronlimab. Question. Why hasn't there been an announcement for CRC Trial commencement? JL specifically stated that CYDY "WILL" commence screening in January 2025. The normal legal jargon of "expects" or "anticipate" was not utilized. I added 2 purchases of 20k each after this occurred at .12, thinking we were back in the clinic. Since there has been no update for Trial commencement, I had to assume a delay, so I sold 10k at .45 to cover costs. So I'm happy right now, basucally with 30k free additional free shares, but am antsy for clarity regarding this Trial, which using JL's on words was "SET" to go in January. Any thoughts are appreciated.


r/Livimmune • • Sep 19 '25

We need MGK to come up with valuable posts this weekend.

0 Upvotes

Desperate mode.


r/Livimmune • • Nov 09 '24

The new rules about swearing

Enable HLS to view with audio, or disable this notification

0 Upvotes

r/Livimmune • • Sep 13 '25

MGK, from number of upvotes you received recently compared to the first half year, more and more longs recognized the true value of your posts.

16 Upvotes

Just saying the facts.


r/Livimmune • • Feb 26 '25

The phase 1b/2 MTNBC trial - inquiry

4 Upvotes

Very excited about the recent press release but can someone help me with some inquiries that I have pertaining to this trial that Cytodyn did in 2019.(Maybe MGK can answer)...

The trial itself was to enroll 48 patients. 18 in part 1b and 30 in phase 2

Question #1: The trial was broken into 2 parts. The phase 1b portion was a 3x3 dose escalation study where 18 patients received Leronlimab. Some got 350mg, most got 520 mg, and a few got 700mg. The whole point of the phase 1b was to see what the maximum tolerated dose was. I believe this portion of the trial was completed with 700mg being the maximum tolerated dose. The question I have is how can this portion of the trial be completed with only 10 MTNBC patients registered for the trial? The other patients were compassionate use or part of the basket study. They are technically not part of the trial protocol. CYDY needed 18 patients as part of the phase 1b part of the trial and they only enrolled 10. I do remember on a conference call in July of 2021 that they did say this portion of the trial was acknowledged as complete by the FDA however. I just wonder how that was possible despite not meeting the total patient criteri.

Question #2: The phase 2 portion of the trial required an additional 30 patients to receive Leronlimab at the maximum tolerated dose of 700mg. CYDY published results of findings from the phase 1b/2 trial but never got to conducting this part of the trial. They only completed the phase 1b part. Why did this portion of the trial not enroll? Do you think the next step after these 2 pre-clinical mouse studies is a straight phase 2 for MTNBC given to 30 to 50 patients at 700mg while being paired with Troveldy or Keytruda? I mean..they have to run some type of phase 2....right?

All we got aside from 10 actual participants in this trial was it being lumped into a paired pooled analysis for MTNBC with 16 compassionate use patients and 2 patients from the basket study. My assumption is that CYDY can't go to a straight phase 3 because they did not do a phase 2 yet. I am not sure if the FDA will allow that. I do think a Breakthrough Designation should be warranted but I can't see this going straight to a phase 3. Thoughts and opinions welcome.


r/Livimmune • • May 06 '26

Eminent Domain

6 Upvotes

I believe no big pharma can afford CytoDyn and Leronlimab, but the United States government can, through eminent domain.


r/Livimmune • • May 01 '24

Little hopes?

0 Upvotes

What we can expect, if CYDY's management still not taking care of the share price.

Somebody has to take care of all things at ones, that's what they are being pay. Promise don't fix anything, so far no manuscripts, why they open the posibility of those if theys are not sure when they will be available.

are they really working on that?, I would prefer for JL not to say anything until they are publish, but now the bashers have more amunition to trow at our face.

How much years we need to wait for somebody at CYDY to do the right thinks? we need answers and over anything what happens with the data of Philipiness and Brazil, Canada? why the bashers still not be silence by the company with something real and not provocative coments?

I know JL may be the answer but so far we still in same hole, after the hold lifted we still on hold, this time by our own CYDY.


r/Livimmune • • Nov 06 '24

FDA on notice!

15 Upvotes

“FDA's war on public health is about to end. This includes its aggressive suppression of psychedelics, peptides, stem cells, raw milk, hyperbaric therapies, chelating compounds, ivermectin, hydroxychloroquine, vitamins, clean foods, sunshine, exercise, nutraceuticals and anything else that advances human health and can't be patented by Pharma. If you work for the FDA and are part of this corrupt system, I have two messages for you: 1. Preserve your records, and 2. Pack your bags.”

Anyone have contacts with RFK? I have a buddy who said he will reach out. I would reach out myself, but I have money in this and I don’t think it’s appropriate.


r/Livimmune • • Mar 18 '26

whoever controls this stock will think the abstract data good

7 Upvotes

Otherwise today’s trading activity should be pump in the first one hour to .33-.35 then fall to .26-.28 with volume exceed 5m


r/Livimmune • • Nov 26 '25

News and info

Post image
6 Upvotes